Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chignard

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Haemostasis|January 1, 1989
Reduced sensitivity of human platelets to PAF-acether following ticlopidine intakeM Chignard, C Lalau Keraly, D Delautier, et al.
The Journal of Biological Chemistry|April 25, 1997
Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. Involvement in the potentiation of platelet aggregationM Si-Tahar, D Pidard, V Balloy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophagesL Salez, V Balloy, N van Rooijen, et al.
Blood|March 15, 1997
Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptorP Renesto, M Si-Tahar, M Moniatte, et al.
FEBS Letters|November 18, 2000
Phosphoinositide 3-kinase inhibition reverses platelet aggregation triggered by the combination of the neutrophil proteinases elastase and cathepsin G without impairing alpha(IIb)beta(3) integrin activationC Trumel, M Si-Tahar, V Balloy, et al.
European Journal of Pharmacology|April 16, 1986
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988D Nunez, M Chignard, R Korth, et al.
Prostaglandins|May 1, 1985
Leukocytic functions in burn-injured patientsM Braquet, P Lavaud, D Dormont, et al.
European Journal of Pharmacology|November 19, 1986
Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigsE Coëffier, M C Borrel, J Lefort, et al.
British Journal of Haematology|June 1, 1981
Constitutional thrombocytopathy with subnormal response to thromboxane A2M Samama, C Lecrubier, J Conard, et al.
Thrombosis Research|April 1, 1985
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitroI Juhan-Vague, M Chignard, C Poisson, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Haemostasis|January 1, 1989
Reduced sensitivity of human platelets to PAF-acether following ticlopidine intakeM Chignard, C Lalau Keraly, D Delautier, et al.
The Journal of Biological Chemistry|April 25, 1997
Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. Involvement in the potentiation of platelet aggregationM Si-Tahar, D Pidard, V Balloy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophagesL Salez, V Balloy, N van Rooijen, et al.
Blood|March 15, 1997
Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptorP Renesto, M Si-Tahar, M Moniatte, et al.
FEBS Letters|November 18, 2000
Phosphoinositide 3-kinase inhibition reverses platelet aggregation triggered by the combination of the neutrophil proteinases elastase and cathepsin G without impairing alpha(IIb)beta(3) integrin activationC Trumel, M Si-Tahar, V Balloy, et al.
European Journal of Pharmacology|April 16, 1986
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988D Nunez, M Chignard, R Korth, et al.
Prostaglandins|May 1, 1985
Leukocytic functions in burn-injured patientsM Braquet, P Lavaud, D Dormont, et al.
European Journal of Pharmacology|November 19, 1986
Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigsE Coëffier, M C Borrel, J Lefort, et al.
British Journal of Haematology|June 1, 1981
Constitutional thrombocytopathy with subnormal response to thromboxane A2M Samama, C Lecrubier, J Conard, et al.
Thrombosis Research|April 1, 1985
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitroI Juhan-Vague, M Chignard, C Poisson, et al.
Pageof 8